Flixotide

Medicinal product

(Invented) name

Flixotide

Active substance (s)

Flutikazonas

Strength

125 µg/dozėje

Pharmaceutical form

suslėgtoji įkvepiamoji suspensija

Route (s) of administration

įkvėpti

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R03BA05, Fluticasone

Marketing authorisation holder

UAB Limedika, Lietuva

Date of authorisation

2021-05-04

Date of renewal

Documents

1514_Flixotide_2022-01-27.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

dozėje yra	1 dozėje
Flutikazonas	125 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
106481	92582	1092582	slėginė talpyklė	60 dozių		Receptinis	LT/L/21/1514/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2021-05-04	Registruotas